Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.

Watanabe R, Ohyama C, Aoki H, Takahashi T, Satoh M, Saito S, Hoshi S, Ishii A, Saito M, Arai Y.

Cancer Res. 2002 Jul 1;62(13):3850-4.

2.

Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44.

Golshani R, Lopez L, Estrella V, Kramer M, Iida N, Lokeshwar VB.

Cancer Res. 2008 Jan 15;68(2):483-91. doi: 10.1158/0008-5472.CAN-07-2140.

3.

In vitro activation of cancer patient-derived dendritic cells by tumor cells genetically modified to express CD154.

Loskog A, Tötterman TH, Böhle A, Brandau S.

Cancer Gene Ther. 2002 Oct;9(10):846-53.

4.
5.

HYAL1-v1, an alternatively spliced variant of HYAL1 hyaluronidase: a negative regulator of bladder cancer.

Lokeshwar VB, Estrella V, Lopez L, Kramer M, Gomez P, Soloway MS, Lokeshwar BL.

Cancer Res. 2006 Dec 1;66(23):11219-27.

6.

HYAL1 hyaluronidase: a molecular determinant of bladder tumor growth and invasion.

Lokeshwar VB, Cerwinka WH, Lokeshwar BL.

Cancer Res. 2005 Mar 15;65(6):2243-50.

7.

Enhanced GM3 expression, associated with decreased invasiveness, is induced by brefeldin A in bladder cancer cells.

Satoh M, Ito A, Nojiri H, Handa K, Numahata K, Ohyama C, Saito S, Hoshi S, Hakomori SI.

Int J Oncol. 2001 Oct;19(4):723-31.

PMID:
11562747
8.

Overexpression of cyclooxygenase-2 (COX-2) in the mouse urinary bladder induces the expression of immune- and cell proliferation-related genes.

Wang X, Colby JK, Rengel RC, Fischer SM, Clinton SK, Klein RD.

Mol Carcinog. 2009 Jan;48(1):1-13. doi: 10.1002/mc.20449.

PMID:
18444251
9.

In vitro and in vivo effects of CpG-Oligodeoxynucleotides (CpG-ODN) on murine transitional cell carcinoma and on the native murine urinary bladder wall.

Olbert PJ, Schrader AJ, Simon C, Dalpke A, Barth P, Hofmann R, Hegele A.

Anticancer Res. 2009 Jun;29(6):2067-76.

10.

Overexpression of alpha-defensin is associated with bladder cancer invasiveness.

Holterman DA, Diaz JI, Blackmore PF, Davis JW, Schellhammer PF, Corica A, Semmes OJ, Vlahou A.

Urol Oncol. 2006 Mar-Apr;24(2):97-108.

PMID:
16520271
13.
14.

Decreased Fas expression in advanced-stage bladder cancer is not related to p53 status.

Maas S, Warskulat U, Steinhoff C, Mueller W, Grimm MO, Schulz WA, Seifert HH.

Urology. 2004 Feb;63(2):392-7.

PMID:
14972509
15.

Overexpression of immunoglobulin G prompts cell proliferation and inhibits cell apoptosis in human urothelial carcinoma.

Liang PY, Li HY, Zhou ZY, Jin YX, Wang SX, Peng XH, Ou SJ.

Tumour Biol. 2013 Jun;34(3):1783-91. doi: 10.1007/s13277-013-0717-z.

16.

Livin may serve as a marker for prognosis of bladder cancer relapse and a target of bladder cancer treatment.

Liu HB, Kong CZ, Zeng Y, Liu XK, Bi JB, Jiang YJ, Han S.

Urol Oncol. 2009 May-Jun;27(3):277-83. doi: 10.1016/j.urolonc.2008.03.015.

PMID:
18555709
18.

Fibulin-5 is down-regulated in urothelial carcinoma of bladder and inhibits growth and invasion of human bladder cancer cell line 5637.

Hu Z, Ai Q, Xu H, Ma X, Li HZ, Shi TP, Wang C, Gong DJ, Zhang X.

Urol Oncol. 2011 Jul-Aug;29(4):430-5. doi: 10.1016/j.urolonc.2009.06.004.

PMID:
19767220
19.

Antitumor activity of fibroblast growth factor receptor 3-specific immunotoxins in a xenograft mouse model of bladder carcinoma is mediated by apoptosis.

Martínez-Torrecuadrada JL, Cheung LH, López-Serra P, Barderas R, Cañamero M, Ferreiro S, Rosenblum MG, Casal JI.

Mol Cancer Ther. 2008 Apr;7(4):862-73. doi: 10.1158/1535-7163.MCT-07-0394.

Items per page

Supplemental Content

Support Center